Healthcare / Medical - Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

FRA/ECX stock hub

FRA/ECX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/ECXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

815.6K

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/ECX

In the news

Latest news · FRA/ECX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-31,400

P25 -6.7P50 8.5P75 17.2

ROIC-2.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/ECX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

EUR

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	3
Employees Change	1%
Employees Change Percent	50
Enterprise value	EUR 11.8M
Exchange	Frankfurt Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	DE000A37FT41
Last refreshed	2026-05-10
Market cap	EUR 815,588
Price	EUR 0.93
Price currency	EUR
Rev Per Employee	8,000x
Sector	Healthcare
Sic	2835
Symbol	fra/ECX
Website	https://www.epigenomics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-38.5%
EV Earnings	-37.52x
P/B ratio	407.79x
P/S ratio	33.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	EUR 24,000
Gross Profit Growth	500%
Gross Profit Growth3 Y	-41.84%
Gross Profit Growth5 Y	-41.22%
Net Income	EUR -314,000
Pretax Margin	-1,308.33%
Profit Per Employee	EUR -104,667
ROA	-2.03
Roa5y	-16.4
ROCE	-3.31
ROE	-31,400
ROIC	-2.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-48.96%
Cagr1y	-5.11%
Cagr3y	-32.13%
Cagr5y	-47.65%
Revenue Growth3 Y	-43.91x
Revenue Growth5 Y	-44.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0
Assets	EUR 11.6M
Cash	EUR 414,000
Current Assets	EUR 439,000
Current Liabilities	EUR 73,999
Debt	EUR 11.4M
Debt Equity	EUR 5,691
Equity	EUR 2,000
Liabilities	EUR 11.6M
Long Term Assets	EUR 11.2M
Long Term Liabilities	EUR 11.5M
Net Cash	EUR -11M
Net Cash By Market Cap	EUR -1,345
Net Debt Equity	EUR 5,484
Tangible Book Value	EUR 2,000
Tangible Book Value Per Share	EUR 0
WACC	0.65

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.93
Net Working Capital	EUR -48,999
Quick ratio	5.72
Working Capital	EUR 365,001
Working Capital Turnover	EUR 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.88%
1Y total return	-5.1%
200-day SMA	0.92
3Y total return	-68.74%
50-day SMA	0.95
50-day SMA vs 200-day SMA	50over200
5Y total return	-96.07%
All Time High	1,187.4
All Time High Change	-99.92%
All Time High Date	2017-07-05
All Time Low	0.5
All Time Low Change	86%
All Time Low Date	2024-06-28
ATR	0.04
Beta	0.98
Beta1y	-0.14
Beta2y	0.46
Ch YTD	3.33
High	0.93
High52	1.59
High52 Date	2025-11-12
High52ch	-41.51%
Low	0.93
Low52	0.5
Low52 Date	2025-06-27
Low52ch	86%
Ma50ch	-2.15%
Price vs 200-day SMA	1.46%
RSI	48.62
RSI Monthly	33.69
RSI Weekly	49.41
Sharpe ratio	0.62x
Sortino ratio	1.19
Total Return	-0%
Tr YTD	3.33
Tr1m	6.9%
Tr3m	6.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -382,000
Operating margin	-1,591.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	622,111%
Shares Institutions	0%
Shares Out	876,976
Shares Qo Q	0.01%
Shares Yo Y	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	333.95x
Bv Per Share	0
Ch10y	-99.89
Ch1m	6.9
Ch1y	-5.1
Ch3m	6.9
Ch3y	-68.74
Ch5y	-96.07
Ch6m	4.49
Change	-0.53%
Change From Open	0
Close	0.94
Days Gap	-0.53
Depreciation Amortization	12,000
Earnings Date	2026-05-29
EBIT	EUR -382,000
EBITDA	EUR -370,000
EPS	EUR -0.36
F Score	1
Fiscal Year End	December
Founded	1,998
Investing CF	20,000
Is Primary Listing	1
Last Earnings Date	2025-11-10
Last Report Date	2025-12-31
Last Split Date	2023-12-08
Last Split Type	Reverse
Ma150	0.93
Ma150ch	0.39%
Ma20	0.95
Ma20ch	-2.26%
Net CF	-514,000
Next Earnings Date	2026-05-29
Open	0.93
Price Date	2026-05-08
Ptbv Ratio	407.8
Relative Volume	0.08x
Revenue	24,000x
Tr6m	4.49%
Z Score	-10.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/ECX pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/ECX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/ECX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.0%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

FRA/ECX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.6

Neutral momentum band

Price vs 200-day MA

+1.5%

50/200-day relationship not available

Beta (5Y)

0.98

Moves roughly with the market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/ECX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/ECX stock rating?

fra/ECX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/ECX analysis?

The full report lives at /stocks/fra/ECX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/ECX?

The latest report frames fra/ECX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/ECX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.